Typicality: | 0.430 |
Saliency: | 0.421 |
on affects other industries | 9 | transitive-object |
about the proposed drug complexes | 5 | other |
to members | 3 | transitive-object |
administration → provide → further information | 7 |
administration → provide → more information | 7 |
administration → provide → additional information | 5 |
administration → provide → detail | 3 |
administration → provide → more details | 3 |
negative | neutral | positive |
0.109 | 0.800 | 0.091 |
Raw frequency | 25 |
Normalized frequency | 0.421 |
Modifier score | 0.500 |
Perplexity | 210.173 |